sur M1 Kliniken AG (ETR:DE000A0S)
M1 Kliniken AG Reports 35.5% Rise in Nine-Month Beauty EBIT
M1 Kliniken AG has announced a 35.5% increase in its nine-month Beauty EBIT, reaching EUR 28.6 million, surpassing its entire 2025 total. The EBIT margin expanded to 33.0% from 27.1% in the previous year.
The third quarter saw significant growth with earnings climbing 63.9% to EUR 10.0 million. This comes alongside a revenue increase of 11.7%, totaling EUR 29.7 million in Q3 2026.
Despite group revenue declines due to the sale of HAEMATO Pharm GmbH, adjusted EBIT still rose by 21.1%. M1 Kliniken is realigning its focus solely on the Beauty segment after exiting the Trading segment.
Looking forward, the company aims to achieve revenue between EUR 200 million and EUR 300 million by 2029. Expansion plans include increasing its clinic network in Germany and globally, accompanied by a move to the Prime Standard of the Frankfurt Stock Exchange in 2027.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de M1 Kliniken AG